There are currently 20 clinical trials in Melbourne, Florida looking for participants to engage in research studies. Trials are conducted at various facilities, including Florida Eye Associates, GSK Investigational Site, Health First Holmes Regional Medical Center and Pfizer Investigational Site. Whether you're a healthy volunteer looking to participate in paid medical research or seeking trials related to a specific condition, the city provides a diverse range of opportunities near you.
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
NCT03072927
Recruiting
This prospective longitudinal study will compare incidence rates of Medicare beneficiary surgical and minimally invasive intervention post index procedure, as well as harms associated with the MILD procedure, at 24 months post-treatment with MILD, tested against a control group of similar patients that have had a comparable procedure. This study will start with patients treated with a study procedure having an index date on or after January 1, 2017, and enrollment will continue until stopped by... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
04/23/2024
Locations: Melbourne Surgery Center, Melbourne, Florida +2 locations
Conditions: Lumbar Spinal Stenosis
Register for Updates
The Preeclampsia Registry
NCT06377878
Recruiting
The purpose of The Preeclampsia Registry is to collect and store medical and other information from women who have been medically diagnosed with preeclampsia or a related hypertensive (high blood pressure) disorder of pregnancy such as eclampsia or HELLP syndrome, their family members, and women who have not had preeclampsia to serve as controls. Information from participants will be used for medical research to try to understand why preeclampsia occurs, how to predict it better, and to develop... Read More
Gender:
All
Ages:
13 years and above
Trial Updated:
04/17/2024
Locations: Preeclampsia Foundation, Melbourne, Florida
Conditions: Preeclampsia, Eclampsia, HELLP Syndrome, Toxemia, Hypertensive Disorder of Pregnancy
Register for Updates
Long-term Follow-up Study to Evaluate Safety and Immunogenicity of PXVX0317 Single or Booster Vaccination
NCT06007183
Recruiting
The purpose of this phase 3 multicenter, randomized, double-blind, placebo-controlled rollover study is to evaluate the safety and long-term immunogenicity of PXVX0317 in adult and adolescent participants and to evaluate PXVX0317 booster vaccine induced serum neutralizing antibody (SNA) response at 3, 4, or 5 years post-initial PXVX0317 vaccination.
Gender:
All
Ages:
Between 12 years and 67 years
Trial Updated:
03/26/2024
Locations: Optimal Research, LLC, Melbourne, Florida
Conditions: Chikungunya Virus Infection
Register for Updates
4D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration
NCT05197270
Recruiting
Phase 1/2 dose-escalation and randomized, controlled, masked expansion trial in adults with wet AMD undergoing active anti-VEGF treatment
Gender:
All
Ages:
50 years and above
Trial Updated:
02/15/2024
Locations: Florida Eye Associates, Melbourne, Florida
Conditions: Neovascular (Wet) Age-Related Macular Degeneration
Register for Updates
Study of EYP-1901 in Patients With Nonproliferative Diabetic Retinopathy (NPDR)
NCT05383209
Recruiting
A prospective, randomized, double-masked study evaluating the ocular efficacy and safety of two doses of the EYP-1901 intravitreal insert compared to sham
Gender:
All
Ages:
18 years and above
Trial Updated:
02/08/2024
Locations: EyePoint Investigative Site, Melbourne, Florida
Conditions: Nonproliferative Diabetic Retinopathy
Register for Updates
IGC-AD1 Trial on Agitation in Dementia Due to Alzheimer's
NCT05543681
Recruiting
The purpose of this study is to assess the efficacy of an oral medication, IGC-AD1 that is a natural THC-based (Tetrahydrocannabinol) formulation, administered in micro doses, twice a day, on symptomatological Agitation, in patients with mild to severe dementia from Alzheimer's.
Gender:
All
Ages:
60 years and above
Trial Updated:
01/05/2024
Locations: Site 700, Melbourne, Florida
Conditions: Alzheimer Disease, Agitation,Psychomotor, Depression, Anxiety, Memory Impairment, Care Giving Burden, NPS, Agitated; State, Acute Reaction to Stress, Aggression, Aggressive Outburst
Register for Updates
Safety and Efficacy of AM712 in Patients With nAMD
NCT05345769
Recruiting
The purpose of this Phase 1 study is comprised of multiple ascending-dose component (Part 1) and high concentration component (Part 2) to evaluate the safety, tolerability, pharmacokinetics, and efficacy of AM712 in patients with neovascular age- related macular degeneration (nAMD).
Gender:
All
Ages:
50 years and above
Trial Updated:
07/24/2023
Locations: Florida Eye Associates, Melbourne, Florida
Conditions: Neovascular Age-related Macular Degeneration
Register for Updates
The Preeclampsia Registry
NCT02020174
Recruiting
The purpose of The Preeclampsia Registry is to collect and store medical and other information from women who have been medically diagnosed with preeclampsia or a related hypertensive (high blood pressure) disorder of pregnancy such as eclampsia or HELLP syndrome, their family members, and women who have not had preeclampsia to serve as controls. Information from participants will be used for medical research to try to understand why preeclampsia occurs, how to predict it better, and to develop... Read More
Gender:
All
Ages:
13 years and above
Trial Updated:
03/18/2021
Locations: Preeclampsia Foundation, Melbourne, Florida
Conditions: Preeclampsia, Eclampsia, HELLP Syndrome, Toxemia, Hypertensive Disorder of Pregnancy
Register for Updates